Autres langues UCB

Actions

UCB

BE0003739530

Produits pharmaceutiques

Marché Fermé - Euronext Bruxelles Autres places de cotation 17:55:00 07/08/2026			Varia. 5j.	Varia. 1 janv.
223,10 ^EUR	-0,84%		+2,81%	-6,50%

05/08	UCB publie les résultats d'une analyse de données post hoc sur Fintepla chez les patients atteints du syndrome de Lennox-Gastaut	CI
03/08	Avis d'analystes du jour : Stellantis toujours sous pression, KBW revalorise les banques françaises

Autres langues

05/08	UCB Publishes Results Of Post Hoc Data Analysis Of Fintepla In Patients With Lennox-Gastaut Syndrome
03/08	Barclays verlaagt koersdoel UCB
03/08	Jefferies haalt UCB van de verkooplijst
02/08	Umicore en Syensqo blinken uit na cijfers
30/07	UCB SA Reports Earnings Results for the Half Year Ended June 30, 2026
30/07	Nieuwe outlook UCB schiet tekort
30/07	Goede eerste jaarhelft voor UCB
30/07	Goede eerste jaarhelft voor UCB
30/07	UCB shares fall despite guidance upgrade as CEO flags higher H2 costs
30/07	UCB : Delivering today, shaping what comes next
30/07	UCB verhoogt verwachting na sterk halfjaar
30/07	Biopharmaceutical Company UCB Books Higher H1 Profit, Revenue
30/07	UCB raises guidance for core earnings and revenue
30/07	UCB : Delivers Strong Results, Raises 2026 Guidance and Positions for Next Growth Phase
29/07	Omzetgroei bij UCB verwacht
24/07	Bedrijfskalender van 27 tot 31 juli 2026
24/07	Calendario delle società: 27 - 31 luglio 2026
14/07	Where would AI lead Pharma in the long run?
13/07	Antengene Receives $60 Million Milestone in UCB Licensing Deal
12/07	Melexis onderuit in Brussel te midden van AI-malaise
09/07	UK Life Sciences Hits GBP3 Billion Investment Milestone
08/07	UCB presenteert nieuwe studiedata
08/07	UCB : presents latest data from its targeted generalized myasthenia gravis treatment portfolio at International Congress on Neuromuscular Diseases 2026
03/07	UCB : FASTRAX working session highlights progress in axSpA diagnosis
03/07	Berenberg Updates Price Target, Estimates for UCB on Recent Pipeline Deals